Brief: Context Therapeutics Amends Sales Deal, May Sell Up To $75 Million in Common Stock – SEC Filing
24/10/2025 21:29
Oct 24 (Reuters) - Context Therapeutics Inc CNTX.O: CONTEXT THERAPEUTICS: AMENDS SALES AGREEMENT, MAY OFFER & SELL FROM TIME TO TIME COMMON STOCK OF UP TO $75 MILLION - SEC FILING Source text: [ID:n0001628280-25-046256] Further company coverage: CNTX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Context Therapeutics
See all newsContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Context Therapeutics Q2 net loss widens on higher R&D costs
Context Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Context Therapeutics Announces Positive Interim Efficacy And Safety Results From Ongoing Phase 1 Clinical Trial For CTIM-76
Brief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202